Internal Medicine, Rheumatology · Hopkinsville, KY
NPI
1124005038
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1830 High St Ste A
Hopkinsville, KY, 42240
Phone (270) 885-3876
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
271,911 services
Medicare patients, 2024
752
Average age 73
Drug cost, 2024
$1.4M
4,323 prescriptions
Company payments, 2025
$89.98
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kishorkumar A Desai was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 243,200 times for 65 patients. In total Kishorkumar A Desai billed 271,911 services in 32 codes, and Medicare paid $1.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-01.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 243,200 | 65 | $3.62 | $880K |
| J0897 Injection, denosumab, 1 mg | Office | 6,540 | 62 | $20.54 | $134K |
| 99213 Office E&M - Established | Office | 2,027 | 693 | $58.11 | $118K |
| 96372 Injection Administration | Office | 1,406 | 134 | $9.81 | $14K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,242 | 115 | $0.70 | $868 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 888 | 479 | $12.07 | $11K |
| 99214 Office E&M - Established | Office | 337 | 208 | $80.17 | $27K |
| 20610 Joint Injection | Office | 150 | 87 | $45.84 | $6,876 |
| 99204 Office E&M - New | Office | 112 | 112 | $108.48 | $12K |
| 96365 Intravenous Infusion, Hydration | Office | 96 | 12 | $43.15 | $4,142 |
| 73130 X-ray - Upper Extremity | Office | 36 | 18 | $20.69 | $745 |
By year: 2022 $1.7M for 241,635 services; 2023 $1.6M for 259,451 services; 2024 $1.5M for 271,911 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 25 | 12 | $8.40 | $210 |
Medicare prescription drug claims, 2024
In 2024, the drug Kishorkumar A Desai prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 958 prescriptions and refills. In total Kishorkumar A Desai wrote 4,323 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 958 | 1,641 | 192 | $19K |
| Hydroxychloroquine Sulfate Generic | 757 | 1,336 | 157 | $23K |
| Prednisone Generic | 497 | 730 | 130 | $3,437 |
| Leflunomide Generic | 179 | 354 | 41 | $11K |
| Duloxetine Hcl Generic | 175 | 292 | 48 | $2,285 |
| Diclofenac Sodium Generic | 162 | 206 | 33 | $2,085 |
| Meloxicam Generic | 147 | 300 | 45 | $750 |
| Sulfasalazine Generic | 142 | 295 | 39 | $2,408 |
| Alendronate Sodium Generic | 125 | 242 | 27 | $825 |
| Folic Acid Generic | 123 | 192 | 23 | $508 |
| Leucovorin Calcium Generic | 111 | 181 | 21 | $696 |
| Tramadol Hcl Generic | 81 | 81 | 20 | $744 |
| Gabapentin Generic | 77 | 127 | 16 | $723 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 69 | 69 | 19 | $1,020 |
| Probenecid-Colchicine Probenecid/Colchicine | 62 | 128 | 16 | $3,550 |
Brand drugs: 318 claims; generic drugs: 4,005 claims; opioid claims: 171.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kishorkumar A Desai $89.98 ($89.98 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $63.05.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.